Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr144 Inhibitors

Olr144 inhibitors are a distinct class of chemical compounds that specifically target the Olr144 receptor, a protein that is part of the olfactory receptor family, which belongs to the larger group of G-protein coupled receptors (GPCRs). The Olr144 receptor is involved in the detection of specific chemical signals and plays a role in the intricate process of signal transduction, where external signals are converted into cellular responses. Inhibitors of Olr144 are designed to bind to the receptor, preventing its natural ligands from interacting with it. This inhibition can lead to the modulation of downstream signaling pathways that are triggered upon receptor activation. The development of Olr144 inhibitors typically involves the design and synthesis of small molecules that can effectively interact with the receptor, often requiring a deep understanding of the receptor's structure and the binding dynamics of its active site.

The chemical design of Olr144 inhibitors focuses on optimizing several key properties, such as binding affinity, selectivity for the Olr144 receptor over other similar receptors, and chemical stability. Researchers often use techniques like molecular docking, high-throughput screening, and structure-activity relationship (SAR) studies to identify potential inhibitors and refine their chemical structures for improved efficacy. These inhibitors can vary in their chemical composition, including differences in their core scaffolds, functional groups, and stereochemistry, which all contribute to their overall ability to inhibit the Olr144 receptor. Additionally, factors such as lipophilicity, solubility, and metabolic stability are crucial considerations during the development process to ensure that these inhibitors can effectively interact with the Olr144 receptor under physiological conditions. The study and refinement of Olr144 inhibitors provide valuable insights into the chemical mechanisms underlying receptor inhibition and offer a deeper understanding of the biological roles of the Olr144 receptor in various cellular environments.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Erlotinib, Free Base

183321-74-6sc-396113
sc-396113A
sc-396113B
sc-396113C
sc-396113D
500 mg
1 g
5 g
10 g
100 g
$87.00
$135.00
$293.00
$505.00
$3827.00
42
(0)

EGFR inhibitor, potentially disrupts growth factor signaling pathways that Olr144 may be involved in.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

Kinase inhibitor, could influence multiple signaling pathways, possibly impacting Olr144.

ABT-199

1257044-40-8sc-472284
sc-472284A
sc-472284B
sc-472284C
sc-472284D
1 mg
5 mg
10 mg
100 mg
3 g
$118.00
$337.00
$520.00
$832.00
$1632.00
10
(0)

BCL-2 inhibitor, might modulate apoptosis pathways potentially linked to Olr144.

Palbociclib

571190-30-2sc-507366
50 mg
$321.00
(0)

CDK4/6 inhibitor, may affect cell cycle regulation pathways involving Olr144.

Sunitinib Malate

341031-54-7sc-220177
sc-220177A
sc-220177B
10 mg
100 mg
3 g
$197.00
$520.00
$1093.00
4
(1)

Multi-kinase inhibitor, could impact angiogenesis and other signaling pathways related to Olr144.

Lapatinib

231277-92-2sc-353658
100 mg
$420.00
32
(1)

Dual EGFR and HER2 inhibitor, potentially disrupts pathways Olr144 is involved in.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Proteasome inhibitor, might affect protein degradation processes involving Olr144.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$70.00
$145.00
51
(1)

Src family kinase inhibitor, can modulate signaling pathways where Olr144 may be involved.

Nilotinib

641571-10-0sc-202245
sc-202245A
10 mg
25 mg
$209.00
$413.00
9
(1)

BCR-ABL inhibitor, potentially influences signaling pathways related to Olr144's function.

Everolimus

159351-69-6sc-218452
sc-218452A
5 mg
50 mg
$131.00
$651.00
7
(1)

mTOR inhibitor, can modulate cell growth and survival pathways possibly involving Olr144.